Rossmore Private Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Rossmore Private Capital’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,209	Closed	-$371K	–	237
2023 Q3	$371K	Hold	3,209	–	–	0.06%	176
2023 Q2	$330K	Hold	3,209	–	–	0.05%	189
2023 Q1	$350K	Hold	3,209	–	–	0.05%	183
2022 Q4	$365K	Buy	+3,209	New	+$267K	0.06%	172
2022 Q3	–	Sell	-3,129	Closed	-$250K	–	230
2022 Q2	$250K	Buy	3,129 +650	+26%	+$61.6K	0.04%	199
2022 Q1	$261K	Hold	2,479	–	–	0.04%	202
2021 Q4	$267K	Hold	2,479	–	–	0.04%	201
2021 Q3	$272K	Hold	2,479	–	–	0.05%	198
2021 Q2	$232K	Hold	2,479	–	–	0.04%	209
2021 Q1	$228K	Buy	+2,479	New	+$209K	0.04%	198
2018 Q1	–	Sell	-2,479	Closed	-$36.2K	–	440
2017 Q4	$36.2K	Buy	+2,479	New	+$34.8K	0.04%	192

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Rossmore Private Capital's HZNP Position: Q4 2023 in Review

Rossmore Private Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,209 shares — an estimated $371K sold.

Rossmore Private Capital first reported a position in HZNP in Q4 2017 and held it in 11 quarters. The position peaked at $371K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Rossmore Private Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Rossmore Private Capital sold 3,209 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $371K.
Rossmore Private Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2017 and held it in 11 quarters.
Rossmore Private Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $371K in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Rossmore Private Capital's 13F filing for Q4 2023, filed 7 Feb 2024.